Inventor · disambiguated record
Joel R. Walker
Also filed as: WALKER JOEL · WALKER JOEL R
36 granted patents·9 pending applications·92 citations·filing 2006–2025
96Inventor score
Files withPROMEGA CORP24TETRA DISCOVERY PARTNERS LLC8ONCOTHERAPY SCIENCE INC4CHANDRASEKHAR JAYARAMAN2MATSUO YO2
Top patents by PatentIndex Score
45 records- 0196US11767334B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2022·Granted Sep 26, 2023·2 cites·14 claims
- 0294US10815247B2Functionalized NANOLUC inhibitorsPROMEGA CORP·Filed 2017·Granted Oct 27, 2020·11 cites·40 claims
- 0393US10308975B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2018·Granted Jun 4, 2019·4 cites·16 claims
- 0493US10000500B2Coelenterazine analoguesPROMEGA CORP·Filed 2017·Granted Jun 19, 2018·6 cites·20 claims
- 0592US10626129B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2019·Granted Apr 21, 2020·3 cites·13 claims
- 0692US10093686B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2017·Granted Oct 9, 2018·8 cites·34 claims
- 0792US9924073B2Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereofPROMEGA CORP·Filed 2017·Granted Mar 20, 2018·5 cites·10 claims
- 0891US11401286B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2020·Granted Aug 2, 2022·2 cites·12 claims
- 0991US10428075B2Coelenterazine analoguesPROMEGA CORP·Filed 2018·Granted Oct 1, 2019·4 cites·14 claims
- 1090US9777024B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2015·Granted Oct 3, 2017·7 cites·34 claims
- 1189US9221843B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2013·Granted Dec 29, 2015·8 cites·36 claims
- 1288US10364258B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2018·Granted Jul 30, 2019·4 cites·38 claims
- 1388US10280447B2Substituted imidazo[1,2-A]pyrazines tethered to energy acceptorsPROMEGA CORP·Filed 2017·Granted May 7, 2019·4 cites·20 claims
- 1487US12264169B2Heteroaryl inhibitors of PDE4TETRA DISCOVERY PARTNERS LLC·Filed 2023·Granted Apr 1, 2025·0 cites·31 claims
- 1587US9120749B2Quinoline derivatives and MELK inhibitors containing the sameMATSUO YO·Filed 2011·Granted Sep 1, 2015·14 cites·17 claims
- 1687US2025340923A1SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS LUCIFERASE SUBSTRATESPROMEGA CORP·Filed 2025·Application pending·0 cites
- 1786US10316070B2Dual protected pro-coelenterazine substratesPROMEGA CORP·Filed 2017·Granted Jun 11, 2019·3 cites·20 claims
- 1881US12391973B2Substituted imidazo[1,2-α]pyrazines as luciferase substratesPROMEGA CORP·Filed 2023·Granted Aug 19, 2025·0 cites·8 claims
- 1978US10577370B2Cell impermeable coelenterazine analoguesPROMEGA CORP·Filed 2017·Granted Mar 3, 2020·1 cites·25 claims
- 2077US11781168B2Process for preparing substituted imidazo[1,2-α]pyrazinesPROMEGA CORP·Filed 2021·Granted Oct 10, 2023·0 cites·12 claims
- 2175US10669568B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2019·Granted Jun 2, 2020·0 cites·13 claims
- 2275US7528114B2C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 2006·Granted May 5, 2009·2 cites·11 claims
- 2373US2024059697A1Coelenterazine analoguesPROMEGA CORP·Filed 2023·Application pending·0 cites
- 2472US11015216B2Substituted imidazo[1,2-a]pyrazines as luciferase substratesPROMEGA CORP·Filed 2020·Granted May 25, 2021·0 cites·8 claims
- 2572US9067937B21,5-naphthyridine derivatives and MELK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2012·Granted Jun 30, 2015·2 cites·15 claims
- 2669US12065421B2Inhibitors of oplophorus luciferase-derived bioluminescent complexesPROMEGA CORP·Filed 2022·Granted Aug 20, 2024·0 cites·20 claims
- 2769US10669280B2Coelenterazine analoguesPROMEGA CORP·Filed 2019·Granted Jun 2, 2020·0 cites·19 claims
- 2868US8962648B2Tricyclic compounds and PBK inhibitors containing the sameNAKAMURA YUSUKE·Filed 2011·Granted Feb 24, 2015·1 cites·14 claims
- 2967US11691976B2Coelenterazine analoguesPROMEGA CORP·Filed 2019·Granted Jul 4, 2023·0 cites·17 claims
- 3066US11192894B2Cell impermeable coelenterazine analoguesPROMEGA CORP·Filed 2019·Granted Dec 7, 2021·0 cites·36 claims
- 3166US9345709B21,5-naphthyridine derivatives and MELK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2015·Granted May 24, 2016·1 cites·12 claims
- 3266US8026220B2C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 2009·Granted Sep 27, 2011·0 cites·6 claims
- 3365US11655247B2Nanoluc suicide substratesPROMEGA CORP·Filed 2019·Granted May 23, 2023·0 cites·9 claims
- 3463US2024150363A1Coelenterazine analoguesPROMEGA CORP·Filed 2023·Application pending·0 cites
- 3561US11390599B2Inhibitors of oplophorus luciferase-derived bioluminescent complexesPROMEGA CORP·Filed 2019·Granted Jul 19, 2022·0 cites·18 claims
- 3661US2020063110A1Thienopyrrole compounds and uses thereofPROMEGA CORP·Filed 2019·Application pending·0 cites
- 3758US10513694B2Thienopyrrole compounds and uses thereofPROMEGA CORP·Filed 2016·Granted Dec 24, 2019·0 cites·25 claims
- 3858US9453025B2Tricyclic compounds and PBK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 3956US2022064696A1Target engagement assay for ras proteinsPROMEGA CORP·Filed 2021·Application pending·0 cites
- 4051US9359322B2C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growthCLAGETT-DAME MARGARET·Filed 2011·Granted Jun 7, 2016·0 cites·28 claims
- 4150US2011190351A1Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the SameONCOTHERAPY SCIENCE INC·Filed 2009·Application pending·0 cites
- 4248US2011263566A17-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the SameMATSUO YO·Filed 2009·Application pending·0 cites
- 4346US8445684B2Nicotinic acetylcholine receptor ligands and the uses thereofCHANDRASEKHAR JAYARAMAN·Filed 2009·Granted May 21, 2013·0 cites·19 claims
- 4444US2011281836A1Silent desensitizers of neuronal NACHR and methods of use thereofWALKER JOEL R·Filed 2010·Application pending·0 cites
- 4537US2013184313A1Nicotinic acetylcholine receptor ligands and the uses thereofCHANDRASEKHAR JAYARAMAN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joel R. Walker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →